# Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects

> **NCT02191657** · PHASE1 · COMPLETED · sponsor: **ApoPharma** · enrollment: 26 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Deferiprone

## Key facts

- **NCT ID:** NCT02191657
- **Lead sponsor:** ApoPharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-05
- **Final completion:** 2010-04
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02191657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02191657, "Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02191657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*